KAPA
Kairos Pharma Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.60
+0.00 +0.30%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$0.62
+0.02 ▲ +2.97%
| Index | - | P/E | - | EPS (ttm) | -0.3 | Insider Own | 42.08% | Shs Outstand | 0.02B | Perf Week | -4.46% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | -4.48% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 4.11% | Short Float | 10.57% | Perf Quarter | -28.36% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 11.62% | Short Ratio | 2.31 | Perf Half Y | -66.57% |
| Sales | 0.00B | P/B | 1.63 | EPS next 5Y | - | ROA | -77.46% | Short Interest | 1.27M | Perf YTD | -15.24% |
| Book/sh | 0.37 | P/C | 2.25 | EPS past 3/5Y | -4.3% -23.37% | ROE | -92.07% | 52W High | -71.48% ($2.11) | Perf Year | -36.98% |
| Cash/sh | 0.27 | P/FCF | - | Sales past 3/5Y | - | ROIC | -66.05% | 52W Low | 50.45% ($0.40) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -41.8% | Gross Margin | - | Volatility(W/M) | 5.92% 9.14% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 16.56 | EPS Q/Q | 15.09% | Profit Margin | - | RSI (14) | 44.23 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 16.56 | Sales Q/Q | - | SMA20 | -0.1% ($0.6) | Beta | 2.01 | Target Price | $4 |
| Payout | - | Debt/Eq | 0 | Earnings | 2025/12/03 | SMA50 | -12.62% ($0.69) | Rel Volume | 0.15 | Prev Close | $0.6 |
| Employees | 4 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -15.57% - | SMA200 | -33.17% ($0.9) | Avg Volume(3M) | 0.55M | Price | $0.6 |
| IPO | 2024/9/16 | Option/Short | No/Yes | Trades | 156 | Volume | 79,924 | Change | 0.3% |
뉴스 로딩 중...